Floatz logo

Fludarabine

Locally Advanced Malignant Solid Neoplasm

City of Hope Medical CenterSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

46 Active assets in the Locally Advanced Malignant Solid Neoplasm cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 2BB
Pembrolizumab
Mayo Clinic
Phase 2BB
Epirubicin
Mayo Clinic
Phase 2BB
Carboplatin
Pamela Munster
Phase 2B
Alpelisib
National Cancer Institute (NCI)
Phase 2B

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →